|
SPATA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.372500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.448100E-04 |
| Normal-vs-Stage2 |
2.440000E-02 |
| Normal-vs-Stage3 |
4.361200E-03 |
| Normal-vs-Stage4 |
1.639560E-02 |
| Stage1-vs-Stage2 |
7.826200E-01 |
| Stage1-vs-Stage3 |
5.333000E-01 |
| Stage1-vs-Stage4 |
7.568600E-01 |
| Stage2-vs-Stage3 |
4.908800E-01 |
| Stage2-vs-Stage4 |
6.266200E-01 |
| Stage3-vs-Stage4 |
9.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.117520E-03 |
| Normal-vs-AfricanAmerican |
1.171480E-04 |
| Normal-vs-Asian |
2.803000E-03 |
| Caucasian-vs-AfricanAmerican |
1.399000E-01 |
| Caucasian-vs-Asian |
2.925200E-01 |
| AfricanAmerican-vs-Asian |
4.227000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.364740E-04 |
| Normal-vs-Female |
2.769900E-02 |
| Male-vs-Female |
1.463560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.796900E-04 |
| Normal-vs-Extreme_Weight |
4.995400E-04 |
| Normal-vs-Obese |
3.837900E-02 |
| Normal-vs-Extreme_Obese |
3.056600E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.825400E-01 |
| Normal_Weight-vs-Obese |
1.049770E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.741000E-01 |
| Extreme_Weight-vs-Obese |
1.886180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.157200E-01 |
| Obese-vs-Extreme_Obese |
1.923570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.689580E-01 |
| Normal-vs-Age(41-60Yrs) |
5.799900E-03 |
| Normal-vs-Age(61-80Yrs) |
8.3703000000046E-05 |
| Normal-vs-Age(81-100Yrs) |
9.214000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.893000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.598800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.278010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.567570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.845830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.281200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.880800E-03 |
| Normal-VS-Type2 PRCC |
3.64779999995068E-06 |
| Normal-VS-KIRP CIMP |
2.013800E-01 |
| Normal-VS-Unclassified PRCC |
4.437200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.059400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.642200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.597170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.113400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.539920E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.020200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21000000000249E-06 |
| Normal-vs-N1 |
3.090400E-02 |
| Normal-vs-N2 |
2.679200E-01 |
| N0-vs-N1 |
3.968000E-01 |
| N0-vs-N2 |
3.254000E-01 |
| N1-vs-N2 |
7.781600E-01 |
|
|
